NEXT Financial Group, Inc - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 64 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
NEXT Financial Group, Inc ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$3,000
-50.0%
1,0000.0%0.00%
-66.7%
Q3 2018$6,000
+100.0%
1,0000.0%0.00%
+200.0%
Q3 2017$3,000
-99.8%
1,0000.0%0.00%
Q2 2017$2,000,000
-33.3%
1,0000.0%0.00%
-100.0%
Q1 2017$3,000,000
+200.0%
1,0000.0%0.00%
Q4 2016$1,000,000
+99900.0%
1,0000.0%0.00%
Q3 2016$1,0001,0000.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 169,578$276,0000.10%
Geneos Wealth Management Inc. 445,200$725,0000.05%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$20,0000.01%
Vivaldi Capital Management LP 19,261$30,0000.01%
Atria Wealth Solutions, Inc. 278,700$454,2810.01%
OSAIC HOLDINGS, INC. 1,302,122$2,123,0000.01%
BARRETT & COMPANY, INC. 4,984$5,6320.00%
Ameritas Advisory Services, LLC 45,302$74,0000.00%
CENTAURUS FINANCIAL, INC. 20,732$34,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 19,255$31,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders